ADRENALINE 1 mg/10 ml (1:10,000) solution for injection in pre-filled syringe

  • Name:

    ADRENALINE 1 mg/10 ml (1:10,000) solution for injection in pre-filled syringe

  • Company:
    info
  • Active Ingredients:

    Adrenaline tartrate

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 29/10/19

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 29/10/2019

Click on this link to Download PDF directly

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 29 October 2019 PIL

Reasons for updating

  • Change to section 2 - what you need to know - contraindications

Updated on 29 October 2019

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects

Free text change information supplied by the pharmaceutical company

Section 4.4: Inclusion of further information regarding sodium.

Section 4.8: addition of new undesirable effect - Takotsubo cardiomypathy

Updated on 9 March 2018 SPC

Reasons for updating

  • Change to section 6.3 - Shelf life
  • Change to section 10 - Date of revision of the text
  • Change to section 6.4 - Special precautions for storage

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Shelf Life extension and revised Special precautions for storage

Updated on 9 March 2018

Reasons for updating

  • New SmPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 25 July 2016 SPC

Reasons for updating

  • New SPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

None provided

Updated on 5 April 2016 PIL

Reasons for updating

  • New PIL for new product